Stay updated on Dapagliflozin in Respiratory Failure Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin in Respiratory Failure Clinical Trial page.

Latest updates to the Dapagliflozin in Respiratory Failure Clinical Trial page
- Check5 days agoChange DetectedStudy locations were updated with many new sites across US, Argentina, Brazil, India, Canada, UK, and others, and several entries were removed; revision tag updated from v3.3.2 to v3.3.3.SummaryDifference2%

- Check12 days agoChange Detected- The location entry for New Delhi, India was corrected from 'Sāket' to 'Saket' (110017) in the study locations.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedRevision: v3.3.2 replaces the previous v3.3.1. No visible changes to study details or page functionality.SummaryDifference0.0%

- Check34 days agoChange DetectedThese changes are minor metadata updates: a PubMed publications note and a revision label (v3.3.1) that do not affect study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check41 days agoChange DetectedRemoved the government funding lapse notice that informed users about potential date-lag and directed them to NIH/OPM status pages. This change does not affect the trial details, eligibility criteria, or outcomes.SummaryDifference0.2%

- Check55 days agoChange DetectedThe Delhi site name shows a diacritic variation ('Sāket' vs 'Saket') with the same postal code 110017, indicating a minor typographical normalization of the location. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Dapagliflozin in Respiratory Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin in Respiratory Failure Clinical Trial page.